Mr. Craig Milne reports

INNOVOTECH INC. ANNOUNCES INTENTION TO APPLY FOR TRADING ON THE OTCQB VENTURE MARKET

Innovotech Inc. intends to obtain a stock quotation in the United States and a trading symbol on the OTC Markets (OTCQB), an over-the-counter venture market. A quotation on the OTCQB will enhance the company's visibility to the investment community with the goal of making the company more accessible to retail and institutional investors in the United States and to increase the liquidity of the company.

The OTCQB quotation operates in parallel with the company's primary Canadian listing. The OTCQB quotation is expected to impose no additional material compliance or reporting requirements. As a foreign private issuer, Innovotech will continue to meet its existing primary market disclosure obligations on SEDAR+, which satisfy OTC market requirements under established foreign issuer exemptions. To be considered for admission to the OTCQB, companies must meet certain financial standards, be current in their reporting obligations, and undergo an annual verification and management certification process.

In conjunction with the listing, the company will also apply for eligibility with the Depository Trust Company, enabling simplified electronic clearing and settlement of its common shares for U.S. investors.

About Innovotech Inc.

Innovotech is a Canadian boutique contract research organization specializing in advanced laboratory services and commercializing proprietary technologies. A leader in biofilm science, the company provides expertise in anti-microbial testing, pharmaceutical analysis and industrial laboratory solutions, supported by innovative methodologies and products including its widely used MBEC assay kit for high-throughput anti-microbial and antibiotic testing. Innovotech serves clients across multiple sectors, delivering customized research and testing services designed to meet rigorous regulatory and scientific standards such as those of the U.S. Food and Drug Administration and Health Canada through its ISO-certified and GMP-accredited laboratories.

We seek Safe Harbor.